ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.620
+0.140 (9.46%)
Dec 20, 2024, 4:00 PM EST - Market closed
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $85.44 million as of December 20, 2024. Its market cap has decreased by -81.46% in one year.
Market Cap
85.44M
Enterprise Value
-45.77M
1-Year Change
-81.46%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $85.44M, a decrease of -91.91%. That is a compound annual growth rate of -43.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 85.44M | -88.48% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assertio Holdings | 80.49M |
| So-Young International | 79.71M |
| Entera Bio | 79.56M |
| 23andMe Holding Co. | 79.06M |
| Adlai Nortye | 78.97M |
| InspireMD | 77.73M |
| Ikena Oncology | 77.70M |
| I-Mab | 77.69M |